A recent study reveals that patients who come off blockbuster slimming jabs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who end traditional lifestyle regimens.
Research printed in a leading health publication shows that while obese individuals often shed substantial amounts of their body weight while using the jabs, the mass is regained at an average rate of 0.8 kg per month once they quit.
"Users using these drugs need to be informed of the danger of quick rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting weight within about one and a half years.
Weighing Treatments
The analysis, which examined 37 of studies involving over 9,000 of patients, compared the effects of these new drugs with conventional dieting.
Researchers point out that people who lose weight through diet and exercise typically see a slower creep back—perhaps 100 grams monthly—once they finish.
Explaining the Quick Regain
Experts suggest the mechanism of the injections explains the amplified rebound.
The injections mimic a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations far above than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is no longer kept in check, making excessive eating a significant risk."
An Ongoing Issue?
Medical guidelines suggest the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, due to the high risk of weight regain, the treatment might need to be ongoing.
This perspective is supported by drug manufacturers, who note that the findings "emphasize the chronic nature of obesity," akin to managing conditions like diabetes.
User Accounts
Users who have discontinued the jabs explain a intense resurgence of hunger.
"I experienced a trigger that goes on and you become ravenous," said an individual.
This difficulty is worsened if patients have not developed permanent lifestyle or habit changes during treatment.
Growing Adoption
Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Use is higher among females compared to males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are powerful agents for weight loss, they are not a magic cure and maintained weight loss likely depends on ongoing behavioural changes.
